We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Lite Strategy, Inc.는 임상 단계 제약 회사로서 암 치료를 위한 새롭고 차별화된 치료법 개발에 주력하고 있습니다. 이 회사는 이전에 MEI Pharma, Inc.로 알려졌으며, 2025년 9월 Lite Strategy, Inc.로 사명을 변경했습니다. Lite Strategy, Inc.는 2000년에 설립되었으며, 캘리포니아 샌디에이고에 본사를 두고 있습니다.